These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23097067)

  • 61. Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP Study.
    Herrmann JJ; Beckers-Wesche F; Baltussen LEHJM; Verdijk MHI; Bellersen L; Brunner-la Rocca HP; Jaarsma T; Pisters R; Sanders-van Wijk S; Rodwell L; Van Royen N; Gommans DHF; Van Kimmenade RRJ
    J Card Fail; 2022 Oct; 28(10):1522-1530. PubMed ID: 35705150
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sildenafil in heart failure with reactive pulmonary hypertension (Sildenafil HF) clinical trial (rationale and design).
    Guglin M; Rajagopalan N; Anaya P; Charnigo R
    Pulm Circ; 2016 Jun; 6(2):161-7. PubMed ID: 27252841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.
    Reddy YN; Borlaug BA
    Eur J Heart Fail; 2017 Jan; 19(1):126-128. PubMed ID: 27873389
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
    Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
    JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials.
    Zhuang XD; Long M; Li F; Hu X; Liao XX; Du ZM
    Int J Cardiol; 2014 Apr; 172(3):581-7. PubMed ID: 24534379
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sustained improvement of clinical status and pulmonary hypertension in patients with severe heart failure treated with sildenafil.
    Urbanowicz T; Straburzyńska-Migaj E; Katyńska I; Araszkiewicz A; Oko-Sarnowska Z; Grajek S; Jemielity M
    Ann Transplant; 2014 Jul; 19():325-30. PubMed ID: 25007352
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Macitentan in pulmonary hypertension due to left ventricular dysfunction.
    Vachiéry JL; Delcroix M; Al-Hiti H; Efficace M; Hutyra M; Lack G; Papadakis K; Rubin LJ
    Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29437943
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension.
    Chowdhury B; Luu AZ; Luu VZ; Kabir MG; Pan Y; Teoh H; Quan A; Sabongui S; Al-Omran M; Bhatt DL; Mazer CD; Connelly KA; Verma S; Hess DA
    Biochem Biophys Res Commun; 2020 Mar; 524(1):50-56. PubMed ID: 31980166
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
    Bermejo J; Yotti R; García-Orta R; Sánchez-Fernández PL; Castaño M; Segovia-Cubero J; Escribano-Subías P; San Román JA; Borrás X; Alonso-Gómez A; Botas J; Crespo-Leiro MG; Velasco S; Bayés-Genís A; López A; Muñoz-Aguilera R; de Teresa E; González-Juanatey JR; Evangelista A; Mombiela T; González-Mansilla A; Elízaga J; Martín-Moreiras J; González-Santos JM; Moreno-Escobar E; Fernández-Avilés F;
    Eur Heart J; 2018 Apr; 39(15):1255-1264. PubMed ID: 29281101
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
    Gheorghiade M; Greene SJ; Butler J; Filippatos G; Lam CS; Maggioni AP; Ponikowski P; Shah SJ; Solomon SD; Kraigher-Krainer E; Samano ET; Müller K; Roessig L; Pieske B;
    JAMA; 2015 Dec; 314(21):2251-62. PubMed ID: 26547357
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
    Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
    Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study.
    Husebye T; Eritsland J; Müller C; Sandvik L; Arnesen H; Seljeflot I; Mangschau A; Bjørnerheim R; Andersen GØ
    Eur J Heart Fail; 2013 May; 15(5):565-72. PubMed ID: 23288914
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation.
    Larsen AI; Lindal S; Myreng K; Ogne C; Kvaløy JT; Munk PS; Aukrust P; Yndestad A; Dickstein K; Nilsen DW
    Europace; 2013 Jun; 15(6):857-64. PubMed ID: 23322010
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized controlled effectiveness trial of reciprocal peer support in heart failure.
    Heisler M; Halasyamani L; Cowen ME; Davis MD; Resnicow K; Strawderman RL; Choi H; Mase R; Piette JD
    Circ Heart Fail; 2013 Mar; 6(2):246-53. PubMed ID: 23388114
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
    Bartunek J; Davison B; Sherman W; Povsic T; Henry TD; Gersh B; Metra M; Filippatos G; Hajjar R; Behfar A; Homsy C; Cotter G; Wijns W; Tendera M; Terzic A
    Eur J Heart Fail; 2016 Feb; 18(2):160-8. PubMed ID: 26662998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.
    McMurray JJ; Krum H; Abraham WT; Dickstein K; Køber LV; Desai AS; Solomon SD; Greenlaw N; Ali MA; Chiang Y; Shao Q; Tarnesby G; Massie BM;
    N Engl J Med; 2016 Apr; 374(16):1521-32. PubMed ID: 27043774
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
    Bartunek J; Terzic A; Davison BA; Filippatos GS; Radovanovic S; Beleslin B; Merkely B; Musialek P; Wojakowski W; Andreka P; Horvath IG; Katz A; Dolatabadi D; El Nakadi B; Arandjelovic A; Edes I; Seferovic PM; Obradovic S; Vanderheyden M; Jagic N; Petrov I; Atar S; Halabi M; Gelev VL; Shochat MK; Kasprzak JD; Sanz-Ruiz R; Heyndrickx GR; Nyolczas N; Legrand V; Guédès A; Heyse A; Moccetti T; Fernandez-Aviles F; Jimenez-Quevedo P; Bayes-Genis A; Hernandez-Garcia JM; Ribichini F; Gruchala M; Waldman SA; Teerlink JR; Gersh BJ; Povsic TJ; Henry TD; Metra M; Hajjar RJ; Tendera M; Behfar A; Alexandre B; Seron A; Stough WG; Sherman W; Cotter G; Wijns W;
    Eur Heart J; 2017 Mar; 38(9):648-660. PubMed ID: 28025189
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.
    Pieske B; Maggioni AP; Lam CSP; Pieske-Kraigher E; Filippatos G; Butler J; Ponikowski P; Shah SJ; Solomon SD; Scalise AV; Mueller K; Roessig L; Gheorghiade M
    Eur Heart J; 2017 Apr; 38(15):1119-1127. PubMed ID: 28369340
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
    Cosmi F; Shen L; Magnoli M; Abraham WT; Anand IS; Cleland JG; Cohn JN; Cosmi D; De Berardis G; Dickstein K; Franzosi MG; Gullestad L; Jhund PS; Kjekshus J; Køber L; Lepore V; Lucisano G; Maggioni AP; Masson S; McMurray JJV; Nicolucci A; Petrarolo V; Robusto F; Staszewsky L; Tavazzi L; Teli R; Tognoni G; Wikstrand J; Latini R
    Eur J Heart Fail; 2018 May; 20(5):888-895. PubMed ID: 29488676
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.
    Bonderman D; Ghio S; Felix SB; Ghofrani HA; Michelakis E; Mitrovic V; Oudiz RJ; Boateng F; Scalise AV; Roessig L; Semigran MJ;
    Circulation; 2013 Jul; 128(5):502-11. PubMed ID: 23775260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.